ABOUT ALTASCIENCES

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining drug development solutions, whether for a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services.

FEATURED CONTENT

FEATURED WEBINARS

CONTACT INFORMATION

Altasciences

1510 Delp Drive

Harleysville, PA 19438

UNITED STATES

Contact: contact@altasciences.com

FEATURED SOLUTIONS

  • Liquid-filled, two-piece capsules offer several advantages over other solid dosage forms, such as ease of scalability and manufacturing, faster absorption, simpler packaging, and higher product stability. Liquid filling also offers the ability to control R&D compounds, which are expensive and in limited supply. They are also known to accelerate product development because they can be made with fewer excipients than other solid dosage forms, such as tablets. 

  • Nanomilling revolutionizes drug delivery by reducing particle size to enhance solubility, bioavailability, and therapeutic efficacy, addressing the challenges of poorly water-soluble APIs.

  • There is a growing demand for the sterilization of small-molecule parenteral products, including heart medications, eye drops, analgesics, and antibiotics, as well as intravenous solutions, such as glucose, potassium, and saline. To ensure patient safety, these drug products and related instruments commonly used in hospitals must be thoroughly sterilized after being manufactured. Known as "terminal sterilization," this highly efficient process ensures that no microbial contaminants like fungi or bacteria are present when the product is used.

    If you have a product that needs to be terminally sterilized, we can help.

  • Proper formulation of active pharmaceutical ingredients (APIs) is essential for achieving therapeutic efficacy, ensuring patient safety, maintaining product stability, optimizing pharmacokinetics, meeting regulatory requirements, and enhancing cost-effectiveness in pharmaceutical development.

  • Altasciences' manufacturing (CDMO) team provides tailored solutions for each phase of your drug development program. From discovery to market ― they’ve got you covered!

  • With our specialized support, you can be confident that your ophthalmic drug will not only meet regulatory standards but also address unmet medical needs in the most expedited manner possible.

  • Our approach is designed to optimize efficiency and accelerate timelines, resulting in up to 40% time savings throughout the early phases of your drug development journey.

  • As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions support programs from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.

  • Explore our collection of capabilities, including liquid-filled capsules, band/sealing technologies, powder, over-encapsulated capsules, topical formulations, and clinical and blister packaging.

  • As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.

FEATURED AUDIO